BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17679408)

  • 1. Antibody response to hepatitis B vaccination in urban, homeless adults.
    Jones T; Nyamathi A; Giger JN; Jacobsen SJ
    J Natl Black Nurses Assoc; 2007 Jul; 18(1):1-7. PubMed ID: 17679408
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid protection against hepatitis A and B using an accelerated vaccination schedule: comparison of combined vaccine, Twinrix, with separate vaccines.
    Nothdurft HD; Dietrich M; Zuckerman JN; Knobloch J; Kern P; Sänger R
    BioDrugs; 2003; 17 Suppl 1():15-8. PubMed ID: 12785873
    [No Abstract]   [Full Text] [Related]  

  • 3. Randomized trial to determine safety and immunogenicity of two strategies for hepatitis B vaccination in healthy urban adolescents in the United States.
    Cunningham CK; Rudy BJ; Xu J; Bethel J; Kapogiannis BG; Ahmad S; Wilson CM; Flynn PM;
    Pediatr Infect Dis J; 2010 Jun; 29(6):530-4. PubMed ID: 20173677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence of antibodies 20 y after vaccination with a combined hepatitis A and B vaccine.
    Van Damme P; Leroux-Roels G; Suryakiran P; Folschweiller N; Van Der Meeren O
    Hum Vaccin Immunother; 2017 May; 13(5):972-980. PubMed ID: 28281907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody persistence and immune memory 4 years post-vaccination with combined hepatitis A and B vaccine in adults aged over 40 years.
    Chlibek R; von Sonnenburg F; Van Damme P; Smetana J; Tichy P; Gunapalaiah B; Leyssen M; Jacquet JM
    J Travel Med; 2011; 18(2):145-8. PubMed ID: 21366801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid and sustained immune response against hepatitis A and B achieved with combined vaccine using an accelerated administration schedule.
    Connor BA; Blatter MM; Beran J; Zou B; Trofa AF
    J Travel Med; 2007; 14(1):9-15. PubMed ID: 17241248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of two different vaccination schemes against Hepatitis A and B in Mexican children and adolescents].
    González-Huezo MS; Sánchez-Avila F; García Mayol M; Castro Narro G; Sixtos S; Lisker-Melman M; Kershenobich D
    Rev Gastroenterol Mex; 2003; 68(4):271-6. PubMed ID: 15125329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation of a hepatitis A/B vaccination program using an accelerated schedule among high-risk inmates, Los Angeles County Jail, 2007-2010.
    Costumbrado J; Stirland A; Cox G; El-Amin AN; Miranda A; Carter A; Malek M
    Vaccine; 2012 Nov; 30(48):6878-82. PubMed ID: 22989688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of the efficacy, immunogenicity and tolerability of a combined hepatitis A and B vaccine.
    Van Damme P; Van Herck K
    Expert Rev Vaccines; 2004 Jun; 3(3):249-67. PubMed ID: 15176942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B vaccination in HIV-infected youth: a randomized trial of three regimens.
    Flynn PM; Cunningham CK; Rudy B; Wilson CM; Kapogiannis B; Worrell C; Bethel J; Monte D; Bojan K;
    J Acquir Immune Defic Syndr; 2011 Apr; 56(4):325-32. PubMed ID: 21350366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination against hepatitis A and B in persons subject to homelessness in inner Sydney: vaccine acceptance, completion rates and immunogenicity.
    Poulos RG; Ferson MJ; Orr KJ; McCarthy MA; Botham SJ; Stern JM; Lucey A
    Aust N Z J Public Health; 2010 Apr; 34(2):130-5. PubMed ID: 23331355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody persistence and immune memory elicited by combined hepatitis A and B vaccination in older adults.
    Höhler T; Groeger-Bicanic G; Hoet B; Stoffel M
    Vaccine; 2007 Feb; 25(8):1503-8. PubMed ID: 17097774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The duration of hepatitis B vaccine immunity in pediatric dialysis patients.
    Sheth RD; Peskin MF; Du XL
    Pediatr Nephrol; 2014 Oct; 29(10):2029-37. PubMed ID: 24839216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of long-term (10 years) immunogenicity of two- and three-dose regimens of a combined hepatitis A and B vaccine in adolescents.
    Beran J; Kervyn D; Wertzova V; Hobzova L; Tichy P; Kuriyakose S; Leyssen M; Jacquet JM
    Vaccine; 2010 Aug; 28(37):5993-7. PubMed ID: 20637766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunisation against hepatitis A, hepatitis B and typhoid fever via combined vaccination: rationale, immunogenicity and reactogenicity.
    Proell S
    BioDrugs; 2003; 17 Suppl 1():7-10. PubMed ID: 12785871
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative immunogenicity and safety of two dosing schedules of a combined hepatitis A and B vaccine in healthy adolescent volunteers: an open, randomised study.
    Burgess MA; Rodger AJ; Waite SA; Collard F
    Vaccine; 2001 Sep; 19(32):4835-41. PubMed ID: 11535336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Randomized Controlled Trial to Evaluate a Potential Hepatitis B Booster Vaccination Strategy Using Combined Hepatitis A and B Vaccine.
    Li F; Hu Y; Zhou Y; Chen L; Xia W; Song Y; Tan Z; Gao L; Yang Z; Zeng G; Han X; Li J; Li J
    Pediatr Infect Dis J; 2017 May; 36(5):e157-e161. PubMed ID: 28060048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized clinical trial of immunization with combined hepatitis A and B versus hepatitis B alone for hepatitis B seroprotection in hemodialysis patients.
    Tung J; Carlisle E; Smieja M; Kim PT; Lee CH
    Am J Kidney Dis; 2010 Oct; 56(4):713-9. PubMed ID: 20630640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A two dose schedule for combined hepatitis A and hepatitis B vaccination in children ages one to eleven years.
    Van Der Wielen M; Van Damme P; Collard F
    Pediatr Infect Dis J; 2000 Sep; 19(9):848-53. PubMed ID: 11001108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term immunogenicity and immune memory after two doses of the adult formulation of a combined hepatitis A and B vaccine in children 1 to 11 years of age.
    van Damme P; Kafeja F; Van Der Wielen M; Leyssen M; Jacquet JM
    Pediatr Infect Dis J; 2011 Aug; 30(8):703-5. PubMed ID: 21346683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.